You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 17, November 7, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Lab Reports
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetics, Other
 •Oncology
 •Alert me on articles by topic

MicroRNA and Metastasis

Tracy Hampton, PhD

JAMA. 2007;298(17):1998.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A particular microRNA (a small regulatory molecule) can cause tumors to metastasize, according to a recent study by scientists at the Whitehead Institute for Biomedical Research, in Cambridge, Mass (Ma L et al. Nature. doi: [published online ahead of print September 26, 2007]). They found that this molecule, called microRNA-10b, is found in much higher levels in metastatic cancer cells than in nonmetastatic cancer cells. In addition, inserting extra copies of the microRNA into nonmetastatic human breast cancer cells forces the cells to become metastatic when injected into the mammary fat pads of mice.

The effects of microRNA-10b were found to occur through a protein called HoxD10, which blocks the expression of genes required for cancer cells to migrate. When the investigators boosted the levels of HoxD10 in the cancer cells with artificially high levels of microRNA-10b, the cells lost their ability to move and invade.

. . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.